Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study

BACKGROUND: Aclidinium/formoterol is a twice-daily (BID) fixed-dose combination (FDC) in development for chronic obstructive pulmonary disease (COPD). The efficacy and safety of aclidinium/formoterol versus monotherapy and placebo in patients with COPD was assessed. METHODS: In this 24-week double-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Jones, Paul W, Bateman, Eric D, Korn, Stephanie, Serra, Cristina, Molins, Eduard, Caracta, Cynthia, Gil, Esther Garcia, Leselbaum, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273456/
https://www.ncbi.nlm.nih.gov/pubmed/25404569
http://dx.doi.org/10.1186/1471-2466-14-178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273456/
https://www.ncbi.nlm.nih.gov/pubmed/25404569
http://dx.doi.org/10.1186/1471-2466-14-178

Ejemplares similares